A-A-51697A
21 July 1987
SUPERSEDING
A-A-0051697 (DM)
26 September 1987
COMMERCIAL ITEM DESCRIPTION
PENTAGASTRIN INJECTION
The General Services Administration has authorized the use of this Commercial Item Description.
Salient Characteristics:
Shall be Pentagastrin Injection.
Shall contain 0.25 mg pentagastrin per ml, 0.88 percent Sodium Chloride, Water for Injection, USP, and Ammonium Hydroxide and/or Hydrochloric Acid to adjust the pH.
Shall contain 0.25 mg pentagastrin per ml, within the applicable assay limits for the injection.
Materials used in the manufacture of the injection shall be of a pharmaceutical grade.
Workmanship. The Injection shall be free from defects which may detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied 2 ml in a commercially available ampul. One package containing ten (10) ampuls, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business